Abstract
Cellular models for siRNA and small molecule high-throughput screening have been widely used in the last decade to identify targets for drug discovery. As an example, we present a twofold readout approach based on cell viability and multipolar phenotype. To maximize the discovery of potential targets and at the same time reduce the number of false positives in our dataset, we have combined focused and rationally designed custom siRNA libraries with small molecule inhibitor libraries. Here we describe a cellular model for centrosome amplification as an example of how to design and perform a multiple readout/multiple screening strategy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Westwick JK, Lamerdin JE (2011) Improving drug discovery with contextual assays and cellular systems analysis. Methods Mol Biol 756:61–73
Schaefer KA, Wu WH, Colgan DF et al (2017) Unexpected mutations after CRISPR-Cas9 editing in vivo. Nat Methods 14:547–548
Dezso Z, Nikolsky Y, Nikolskaya T et al (2009) Identifying disease-specific genes based on their topological significance in protein networks. BMC Syst Biol 23:3–36
Ashworth A, Bernards R (2010) Using functional genetics to understand breast cancer biology. Cold Spring Harb Perspect Biol 2:a003327
Nigg EA, Stearns T (2011) The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol 13:1154–1160
Kwon M, Godinho SA, Chandhok NS et al (2008) Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 22:2189–2203
Zeng X, Sigoillot F, Gaur S et al (2010) Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell 4:382–395
Zhang XD, Yang XC, Chung N et al (2006) Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. Pharmacogenomics 7:299–309
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Drosopoulos, K., Linardopoulos, S. (2019). Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development. In: Moll, J., Carotta, S. (eds) Target Identification and Validation in Drug Discovery. Methods in Molecular Biology, vol 1953. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9145-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9145-7_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9144-0
Online ISBN: 978-1-4939-9145-7
eBook Packages: Springer Protocols